McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Michelle Snyder Brings a Creative Spirit to Marketing and Investing

by McKesson Ventures | Apr 27, 2021 | Media Coverage

Michelle Snyder is McKesson Ventures’ newest partner, having joined the firm in late 2020. But Snyder is a digital health veteran and she’s seen innovation in the industry from every angle, from marketing to mentoring to investing. In a recent StartUp Health Fireside...

Covid-19 serves as catalyst for effort to diversity clinical trial enrollment

by McKesson Ventures | Apr 23, 2021 | Media Coverage

McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...

McKesson Ventures highlights investment priorities amidst a trail of successful exits

by McKesson Ventures | Apr 20, 2021 | Media Coverage

In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in...
Real-World Evidence Should Be Part of Clinical Trials in Oncology

Real-World Evidence Should Be Part of Clinical Trials in Oncology

by McKesson Ventures | Apr 6, 2020 | Media Coverage

McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order...
McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star

McKesson Ventures’ Carrie Hurwitz Williams Recognized as GCV Rising Star

by McKesson Ventures | Jan 29, 2020 | Media Coverage

McKesson Ventures Principal Carrie Hurwitz Williams has been honored as one of 10 Global Corporate Venturing Rising Stars. Williams joined McKesson Ventures in 2017, bringing with her more than 15 years of experience in health care from several vantage points within...
Silicon Valley Boomer Venture Summit Announces Finalists for $10K Business Plan Competition and The Silicon Valley Innovation Competition 2019, Sponsored by AARP Innovation Labs

Silicon Valley Boomer Venture Summit Announces Finalists for $10K Business Plan Competition and The Silicon Valley Innovation Competition 2019, Sponsored by AARP Innovation Labs

by McKesson Ventures | Jun 4, 2019 | Media Coverage

The finalists have been announced for this year’s Business Plan Competition and AARP Innovation Labs Pitch Competition. The business plan competition features companies pitching their ideas to a diverse panel of judges for feedback, funding, and a $10,000 prize....
Page 3 of 9«12345...»Last »

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

Dave Schulte Named as One of GrowthCap’s Top 25 Healthcare Investors of 2024

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow